doi: 10.3810/psm.2009.04.1698.
Effectiveness of the early addition of rosiglitazone to control hyperglycemia after unsuccessful submaximal sulphonylurea monotherapy: the Rosiglitazone Early Versus SULphonylurea Titration (RESULT) Study
Affiliations
- PMID: 20048503
- DOI: 10.3810/psm.2009.04.1698
Item in Clipboard
Effectiveness of the early addition of rosiglitazone to control hyperglycemia after unsuccessful submaximal sulphonylurea monotherapy: the Rosiglitazone Early Versus SULphonylurea Titration (RESULT) Study
Phys Sportsmed.
2009 Apr.
Abstract
Practice Pearl: This study demonstrates the effectiveness of the early addition of rosiglitazone to control hyperglycemia after unsuccessful submaximal sulphonylurea monotherapy. Original Article: Rosenstock J, Goldstein BJ, Vinik AI, et al. RESULT Study Group. Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (> 60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study.
Similar articles
-
Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study.Diabetes Obes Metab. 2006 Jan;8(1):49-57. doi: 10.1111/j.1463-1326.2005.00541.x. Diabetes Obes Metab. 2006. PMID: 16367882 Clinical Trial.
-
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.Diabet Med. 2000 Jan;17(1):40-7. doi: 10.1046/j.1464-5491.2000.00224.x. Diabet Med. 2000. PMID: 10691158 Clinical Trial.
-
Potential benefits of early addition of rosiglitazone in combination with glimepiride in the treatment of type 2 diabetes.Diabetes Obes Metab. 2008 Sep;10(10):862-73. doi: 10.1111/j.1463-1326.2007.00815.x. Epub 2008 Jan 14. Diabetes Obes Metab. 2008. PMID: 18201206 Clinical Trial.
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
-
Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: comparative subgroup analyses of glycemic control and blood lipid levels.Clin Ther. 2003;25 Suppl B:B64-80. doi: 10.1016/s0149-2918(03)80243-6. Clin Ther. 2003. PMID: 14553867 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
